Cargando…
Inactivation of Different Salmonella enteriditis Phage Types and Safety and Efficacy of Inactivated Products in Chicken
This study was conducted to inactivate Salmonella enteriditis phage types (SE pt) and to determine the safety and efficacy of inactivated SE pt in chickens. SE pt 1, 3A, 6A, 7, and 35 were inactivated and inoculated (0.20 mL) in 124 chickens divided into 6 groups (CV1, CV3A, CV6A, CV7, CV35, and CV0...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147547/ https://www.ncbi.nlm.nih.gov/pubmed/34055283 http://dx.doi.org/10.1155/2021/8818308 |
_version_ | 1783697652079132672 |
---|---|
author | Akhtar, A. Hair-Bejo, M. Hussein, Elawad A. Zakaria, Zunita |
author_facet | Akhtar, A. Hair-Bejo, M. Hussein, Elawad A. Zakaria, Zunita |
author_sort | Akhtar, A. |
collection | PubMed |
description | This study was conducted to inactivate Salmonella enteriditis phage types (SE pt) and to determine the safety and efficacy of inactivated SE pt in chickens. SE pt 1, 3A, 6A, 7, and 35 were inactivated and inoculated (0.20 mL) in 124 chickens divided into 6 groups (CV1, CV3A, CV6A, CV7, CV35, and CV0 as a control). Sampling was conducted on day 14 after inoculation (pi). Eight chickens from each group were separated on day 14 pi for oral challenge with 0.20 mL/chicken (10(10) cfu/mL) SE pt 6A and designated CV1C, CV3AC, CV6AC, CV7C, CV35C, and CV0C as control chickens. On days 7 and 14 postchallenge (pc), 4 chickens from every group were sacrificed for sampling. There was no significant difference in the body weight between different groups. In challenged groups, there was no significant association between different tissues and isolation of Salmonella on days 7 and 14 pc. There was significance (p < 0.05) in isolation of Salmonella when CV0C group was compared with other challenged groups. Significance was not observed between different tissues with respect to induction of microscopic changes. Significance was not observed between day 7 pc and day 14 pc with respect to scoring of lesions induced. Clinical signs and gross lesions were also recorded. ELISA was applied. Only in CV3AC group, the mean antibody titer was 1359 on day 14 pc. The conclusion was that inactivated SE pt 3A and 6A were safe and efficacious for protection against Salmonella enteriditis infection in chickens. |
format | Online Article Text |
id | pubmed-8147547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-81475472021-05-27 Inactivation of Different Salmonella enteriditis Phage Types and Safety and Efficacy of Inactivated Products in Chicken Akhtar, A. Hair-Bejo, M. Hussein, Elawad A. Zakaria, Zunita Vet Med Int Research Article This study was conducted to inactivate Salmonella enteriditis phage types (SE pt) and to determine the safety and efficacy of inactivated SE pt in chickens. SE pt 1, 3A, 6A, 7, and 35 were inactivated and inoculated (0.20 mL) in 124 chickens divided into 6 groups (CV1, CV3A, CV6A, CV7, CV35, and CV0 as a control). Sampling was conducted on day 14 after inoculation (pi). Eight chickens from each group were separated on day 14 pi for oral challenge with 0.20 mL/chicken (10(10) cfu/mL) SE pt 6A and designated CV1C, CV3AC, CV6AC, CV7C, CV35C, and CV0C as control chickens. On days 7 and 14 postchallenge (pc), 4 chickens from every group were sacrificed for sampling. There was no significant difference in the body weight between different groups. In challenged groups, there was no significant association between different tissues and isolation of Salmonella on days 7 and 14 pc. There was significance (p < 0.05) in isolation of Salmonella when CV0C group was compared with other challenged groups. Significance was not observed between different tissues with respect to induction of microscopic changes. Significance was not observed between day 7 pc and day 14 pc with respect to scoring of lesions induced. Clinical signs and gross lesions were also recorded. ELISA was applied. Only in CV3AC group, the mean antibody titer was 1359 on day 14 pc. The conclusion was that inactivated SE pt 3A and 6A were safe and efficacious for protection against Salmonella enteriditis infection in chickens. Hindawi 2021-04-13 /pmc/articles/PMC8147547/ /pubmed/34055283 http://dx.doi.org/10.1155/2021/8818308 Text en Copyright © 2021 A. Akhtar et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Akhtar, A. Hair-Bejo, M. Hussein, Elawad A. Zakaria, Zunita Inactivation of Different Salmonella enteriditis Phage Types and Safety and Efficacy of Inactivated Products in Chicken |
title | Inactivation of Different Salmonella enteriditis Phage Types and Safety and Efficacy of Inactivated Products in Chicken |
title_full | Inactivation of Different Salmonella enteriditis Phage Types and Safety and Efficacy of Inactivated Products in Chicken |
title_fullStr | Inactivation of Different Salmonella enteriditis Phage Types and Safety and Efficacy of Inactivated Products in Chicken |
title_full_unstemmed | Inactivation of Different Salmonella enteriditis Phage Types and Safety and Efficacy of Inactivated Products in Chicken |
title_short | Inactivation of Different Salmonella enteriditis Phage Types and Safety and Efficacy of Inactivated Products in Chicken |
title_sort | inactivation of different salmonella enteriditis phage types and safety and efficacy of inactivated products in chicken |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147547/ https://www.ncbi.nlm.nih.gov/pubmed/34055283 http://dx.doi.org/10.1155/2021/8818308 |
work_keys_str_mv | AT akhtara inactivationofdifferentsalmonellaenteriditisphagetypesandsafetyandefficacyofinactivatedproductsinchicken AT hairbejom inactivationofdifferentsalmonellaenteriditisphagetypesandsafetyandefficacyofinactivatedproductsinchicken AT husseinelawada inactivationofdifferentsalmonellaenteriditisphagetypesandsafetyandefficacyofinactivatedproductsinchicken AT zakariazunita inactivationofdifferentsalmonellaenteriditisphagetypesandsafetyandefficacyofinactivatedproductsinchicken |